A critical advance in cancer study is arising with the use of mini-antibodies to restore mutated p53. This essential malignant suppressor protein is frequently inactivated in many types of cancer, resulting https://agency-social.com/story7003111/nanobodies-reactivate-p53-a-promising-pathway-for-cancer-therapy